Human Nature Screening

The the MS Biotechnology program at UW and the Wisconsin Institute for Discovery are partnering to screen the documentary film “Human Nature”, an exploration of gene editing and its implications both biological and ethical.

Jie Liu

  • Postdoctoral Associate

Cross talk between DNA methylation and histone modification

Keerthana Shankar

  • Graduate Student

Virus-free CAR Natural Killer (CAR) NK cell therapies for solid tumors

Xiaoya Zhang

  • Graduate Student

Epigenetic control of cell identity in development and somatic cell reprogramming.

Tiny Capsules Packed with Gene-Editing Tools Offer Alternative to Viral Delivery of Gene Therapy

An interdisciplinary pair of WID researchers has developed a new nanocapsule delivery method for delivering the CRISPR-Cas9 gene editing tool. The new system could be used for many types of gene therapies.

Shivani Saxena

  • Graduate Student

Engineering cells and organism via genome editing and studying the delivery method for CRISPR/Cas9

Hailey Thurston

Hailey Thurston

  • Undergraduate Student

Reprogramming and mechanisms necessary for cell pluripotency.

Amulya Suresh

Amulya Suresh

  • Undergraduate Student

CRISPR-Cas9 Strategy to Generate DOT1L-Deficient Embryonic Stem Cells to Study Pluripotency

Min Zhu

MIn Zhu

  • Graduate Student

Nanoparticles for delivery of therapeutic agents and with gene-editing

Sean Palecek

Sean Palecek

Professor

  • Discovery Fellow

Engineering platforms to regulate human pluripotent stem cell differentiation

UW-Madison to be Partner in Center for Cell Manufacturing Technologies

The National Science Foundation has awarded nearly $20 million to a consortium of universities to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells. Several WID investigators are collaborators on the project.

Caleb Dillingham

Caleb Dillingham

  • Graduate Student

Epigenetic mechanisms of somatic cell reprogramming.